SEC Form 8-K Summary
Registrant: Safety Shot, Inc. The request metadata identifies BONK, Inc., but the filing names Safety Shot, Inc. as the registrant.
Reporting date: January 16, 2024. The filing reports events under Items 7.01 and 8.01 and does not cover a quarterly or annual financial reporting period.
Business Context and Securities
- Safety Shot, Inc. is incorporated in Delaware and is headquartered in Jupiter, Florida.
- Common stock trades on Nasdaq under the symbol SHOT.
- Warrants exercisable for common stock at $8.50 per share trade under SHOTW.
- The company identifies itself as an emerging growth company.
Financial Metrics
The filing does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, balance-sheet data, or other operating financial metrics. No comparable-period financial information is included.
Material Events and Changes
- On January 16, 2024, the company issued a press release furnished as Exhibit 99.1 under Regulation FD.
- On January 10, 2024, Judge Jed S. Rakoff of the U.S. District Court for the Southern District of New York entered an order in Safety Shot, Inc. v. Capybara Research et al., Case No. 1:23-cv-10728-JSR.
- The order permits Safety Shot to serve its summons and complaint on Capybara Research and Igor Appelboom by filing the Form 8-K and publishing the related press release.
- The filing, press release, summons, complaint, and court order are intended to satisfy the constitutional actual-notice requirement under Federal Rule of Civil Procedure 4(f)(3).
Outlook, Risks, and Unusual Items
The principal disclosed matter is ongoing litigation involving Capybara Research and Igor Appelboom. The filing does not state damages, potential financial exposure, settlement terms, expected timing, or the likely outcome of the action. It provides no business guidance or financial outlook.
Investor Verification Points
- Confirm the correct registrant identity: the filing is for Safety Shot, Inc., not BONK, Inc.
- Review Exhibits 99.1 through 99.4, including the press release, summons, complaint, and court order.
- Assess the allegations and potential consequences of the Capybara litigation, including any financial or reputational exposure.
- Use the company’s latest periodic report to verify current revenue, losses, cash position, debt, liquidity, and going-concern disclosures, which are absent from this 8-K.